New “old” polylactides for tissue engineering constructions
- Autores: Antonov E.N.1, Bukharova T.B.2, Dunaev A.G.1, Krotova L.I.1, Nifant’ev I.E.3, Popov V.K.1, Shlyakhtin A.V.3
-
Afiliações:
- Institute of Photon Technologies, Crystallography and Photonics Federal Scientific Research Center
- Medical Genetic Scientific Center
- Moscow State University
- Edição: Volume 8, Nº 5 (2017)
- Páginas: 704-712
- Seção: Materials for Ensuring Human Vital Activity and Environmental Protection
- URL: https://bakhtiniada.ru/2075-1133/article/view/206816
- DOI: https://doi.org/10.1134/S2075113317050033
- ID: 206816
Citar
Resumo
New methods for the synthesis of aliphatic polyesters were proposed and realized with highly effective and low-toxic 1,5,7-triazabicyclo[4.4.0]decene-5 and (2,6-di-tert-butyl-4-methylphenoxy)-butyl-magnesium as catalysts and ethanol as an initiator. The interaction processes between D,L-polylactides of different molecular weights, obtained through these methods, and supercritical carbon dioxide were studied to provide “soft and dry” formation (without high temperatures and toxic organic solvents) of highly porous (up to 90 vol %) bioresorbable matrices for tissue engineering constructions. The chemical structure, molecular weight characteristics, morphology, cytotoxicity, and matrix properties of the samples synthesized from D,L-polylactides were studied with nuclear magnetic resonance spectroscopy, gel permeation chromatography, scanning electron microscopy, colorimetric testing to estimate the metabolic activity of cells (MTT test), and coloration with a vital fluorescent dye of in vitro cultures of multipotent stromal cells of human adipose tissue. A comparative analysis for biocompatibility of these matrices with control samples made from “medical grade” polylactide analog produced industrially indicates that the materials developed can be recommended for tissue engineering.
Sobre autores
E. Antonov
Institute of Photon Technologies, Crystallography and Photonics Federal Scientific Research Center
Autor responsável pela correspondência
Email: e_n_antonov@mail.ru
Rússia, Troitsk, Moscow, 142190
T. Bukharova
Medical Genetic Scientific Center
Email: e_n_antonov@mail.ru
Rússia, Moscow, 115478
A. Dunaev
Institute of Photon Technologies, Crystallography and Photonics Federal Scientific Research Center
Email: e_n_antonov@mail.ru
Rússia, Troitsk, Moscow, 142190
L. Krotova
Institute of Photon Technologies, Crystallography and Photonics Federal Scientific Research Center
Email: e_n_antonov@mail.ru
Rússia, Troitsk, Moscow, 142190
I. Nifant’ev
Moscow State University
Email: e_n_antonov@mail.ru
Rússia, Moscow, 119991
V. Popov
Institute of Photon Technologies, Crystallography and Photonics Federal Scientific Research Center
Email: e_n_antonov@mail.ru
Rússia, Troitsk, Moscow, 142190
A. Shlyakhtin
Moscow State University
Email: e_n_antonov@mail.ru
Rússia, Moscow, 119991
Arquivos suplementares
